Frontiers in Microbiology (Aug 2022)

Therapeutic approaches to colorectal cancer via strategies based on modulation of gut microbiota

  • Maohua Chen,
  • Wei Lin,
  • Wei Lin,
  • Nan Li,
  • Qian Wang,
  • Shaomi Zhu,
  • Anqi Zeng,
  • Linjiang Song

DOI
https://doi.org/10.3389/fmicb.2022.945533
Journal volume & issue
Vol. 13

Abstract

Read online

Colorectal cancer (CRC) ranks third in terms of global incidence and second in terms of death toll among malignant tumors. Gut microbiota are involved in the formation, development, and responses to different treatments of CRC. Under normal physiological conditions, intestinal microorganisms protect the intestinal mucosa, resist pathogen invasion, and regulate the proliferation of intestinal mucosal cells via a barrier effect and inhibition of DNA damage. The composition of gut microbiota and the influences of diet, drugs, and gender on the composition of the intestinal flora are important factors in the early detection of CRC and prediction of the results of CRC treatment. Regulation of gut microbiota is one of the most promising new strategies for CRC treatment, and it is essential to clarify the effect of gut microbiota on CRC and its possible mechanisms to facilitate the prevention and treatment of CRC. This review discusses the role of gut microbiota in the pathogenesis of CRC, the potential of gut microbiota as biomarkers for CRC, and therapeutic approaches to CRC based on the regulation of gut microbiota. It might provide new ideas for the use of gut microbiota in the prevention and treatment of CRC in the near future and thus reduce the incidence of CRC.

Keywords